Autoimmunity: Increasing suspects in the CD4 + T cell lineup

Nature Immunology

Volumn 11, Issue 1, 2010, Pages 36-40

  Palmer, Matthew T ^a   Weaver, Casey T ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 17; CYTOKINE;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL LINEAGE; COMMENSAL; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTOPOIESIS; NONHUMAN; PHENOTYPE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; ARTICLE; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MOUSE; TRANSLATIONAL RESEARCH;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MICE; T-LYMPHOCYTES, HELPER-INDUCER; TRANSLATIONAL RESEARCH;

EID: 74049099080     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1802     Document Type: Review

References (86)

1. Schaerli, P. et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192, 1553-1562 (2000).
2. Breitfeld, D. et al. Follicular B helper T cells express CXC chemokine receptor 5, Localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192, 1545-1552 (2000).
3. Nurieva, R.I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138-149 (2008).
4. Suto, A. et al. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205, 1369-1379 (2008).
5. Johnston, R.J. et al. Bcl6 and Blimp-1 Are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 325, 1006-1010 (2009).
6. Nurieva, R.I. et al. Bcl6 mediates the development of T follicular helper cells. Science 325, 1001-1005 (2009).
7. Yu, D. et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31, 457-468 (2009).
8. H17 cells. Nature 448, 484-487 (2007).
9. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
10. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
11. Vogelzang, A. et al. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 29, 127-137 (2008).
12. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
13. Schmitt, E. et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by iFN-γ. J. Immunol. 153, 3989-3996 (1994).
14. Veldhoen, M. et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346 (2008).
15. - Effector T cells. Nat. Immunol. 9, 1347-1355 (2008).
16. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic Effector TH17 and Regulatory T cells. Nature 441, 235-238 (2006).
17. H17 lineage. Nature 441, 231-234 (2006).
18. Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & stockinger, B. TGFβ in the context of an inflammatory cytokine mILieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
19. Hsieh, C.S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267-277 (2004)
20. Hsieh, C.S., Zheng, Y., Liang, Y., Fontenot, J.D. & Rudensky, A.Y. An intersection between the self-reactive Regulatory and nonRegulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410 (2006).
21. Pan, Z.J., Anderson, C.J. & stafford, H.A. Anti-idiotypic antibodies prevent the sero-logic detection of antiribosomal P autoantibodies in healthy adults. J. Clin. Invest. 102, 215-222 (1998).
22. Oak, S. et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc. Natl. Acad. Sci. USA 105, 5471-5476 (2008).
23. Winslet, M.C., Allan, A., Poxon, V., Youngs, D. & Keighley, M.R. Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process. Gut 35, 236-242 (1994).
24. H17 cell differentiation. Nature 455, 808-812 (2008).
25. Hall, J.A. et al. Commensal DNA limits Regulatory T cell conversion and is a natural adjuvant of intestinal Immune responses. Immunity 29, 637-649 (2008).
26. Elson, C.O. et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and Regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 206, 260-276 (2005).
27. Kroenke, M.A., Carlson, T.J., Andjelkovic, A.V. & Segal, B.M. IL-12-and IL-23-modulated T cells induce distinct types of eAe based on histology, CNs chemokine profILe, and response to cytokine Inhibition. J. Exp. Med. 205, 1535-1541 (2008).
28. Luger, D. et al. Either a Th17 or a Th1 Effector response can drive autoimmunity: conditions of disease induction affect dominant Effector category. J. Exp. Med. 205, 799-810 (2008).
29. Iqbal, N. et al. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J. Exp. Med. 195, 71-84 (2002).
30. Lee, Y.K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92-107 (2009).
31. Linterman, M.A. et al. Follicular helper T cells are required for systemic autoim-munity. J. Exp. Med. 206, 561-576 (2009).
32. Chitnis, T. et al. Effect of targeted disruption of sTAT4 and sTAT6 on the induction of experimental autoImmune encephalomyelitis. J. Clin. Invest. 108, 739-747 (2001).
33. Bettelli, E. et al. Loss of T-bet, but not sTAT1, prevents the development of experimental autoImmune encephalomyelitis. J. Exp. Med. 200, 79-87 (2004).
34. O'Quinn, D.B., Palmer, M.T., Lee, Y.K. & Weaver, C.T. Emergence of the Th17 pathway and its role in host defense. Adv. Immunol. 99, 115-163 (2008).
35. Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoImmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoImmune demyelination. J. Immunol. 169, 7104-7110 (2002).
36. Hue, S. et al. interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473-2483 (2006).
37. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. exp. Med. 203, 2485-2494 (2006).
38. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316 (2006).
39. Becher, B., Durell, B.G. & Noelle, R.J. experimental autoImmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110, 493-497 (2002).
40. Murphy, C.A. et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoImmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
41. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoImmune inflammation of the brain. Nature 421, 744-748 (2003).
42. Zhang, G.X. et al. Induction of experimental autoImmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogen-esis of inflammatory demyelination in the central nervous system. J. Immunol. 170, 2153-2160 (2003).
43. + Effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
44. Refaeli, Y., Van Parijs, L., Alexander, S.I. & Abbas, A.K. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196, 999-1005 (2002).
45. Chu, C.Q., Wittmer, S. & Dalton, D.K. FaILure to suppress the expansion of the activated CD4 T cell population in Interferon γ-deficient mice leads to exacerbation of experimental autoImmune encephalomyelitis. J. Exp. Med. 192, 123-128 (2000).
46. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
47. Chu, C.Q., swart, D., Alcorn, D., Tocker, J. & Elkon, K.B. Interferon-gamma regulates susceptibILity to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 56, 1145-1151 (2007).
48. Weaver, C.T., Hatton, R.D., Mangan, P.R. & Harrington, L.E. IL-17 famILy cytokines and the expanding diversity of Effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007).
49. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to Regulatory T-cell function. Nature 450, 566-569 (2007).
50. + Regulatory T cells do not constitutively express IL-35. J. Immunol. 181, 6898-6905 (2008).
51. Allan, S.E., song-Zhao, G.X., Abraham, T., McMurchy, A.N. & Levings, M.K. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur. J. Immunol. 38, 3282-3289 (2008).
52. Collison, L.W. & Vignali, D.A. Interleukin-35: odd one out or part of the famILy? Immunol. Rev. 226, 248-262 (2008).
53. Becker, C. et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 177, 2760-2764 (2006).
54. Germann, T. et al. Administration of interleukin 12 in combination with type ii collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92, 4823-4827 (1995).
55. Murphy, E. et al. ReversibILity of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183, 901-913 (1996).
56. + T cells, analyzed at the single-cell level. J. exp. Med. 184, 473-483 (1996).
57. Reinhardt, R.L., Liang, H.E. & Locksley, R.M. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat. Immunol. 10, 385-393 (2009).
58. FazILleau, N., McHeyzer-WILliams, L.J., Rosen, H. & McHeyzer-WILliams, M.G. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10, 375-384 (2009).
59. H2 cells in response to helminth antigens. J. Exp. Med. 206, 991-999 (2009).
60. + T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 206, 1001-1007 (2009).
61. Xu, L., Kitani, A., Fuss, I. & strober, W. Cutting edge: Regulatory T cells induce CD4+CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725-6729 (2007).
62. Yang, X.O. et al. Molecular antagonism and plasticity of Regulatory and inflammatory T cell programs. Immunity 29, 44-56 (2008).
63. pos Regulatory T cells differentiate into IL-17-producing cells. blood 112, 2340-2352 (2008).
64. + Regulatory T cells in humans. Proc. Natl. Acad. Sci. USA 106, 4793-4798 (2009).
65. + T cells. Immunity 30, 155-167 (2009).
66. + T cells: a committed Regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106, 1903-1908 (2009).
67. + T cells in gut Peyer's patches. Science 323, 1488-1492 (2009).
68. Lexberg, M.H. et al. Th memory for interleukin-17 expression is stable in vivo. Eur. J. Immunol. 38, 2654-2664 (2008).
69. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoImmune inflammation. J. exp. Med. 201, 233-240 (2005).
70. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655-669 (2000).
71. H1 cells before IL-12-dependent selection. Science 292, 1907-1910 (2001).
72. Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803-2812 (2007).
73. H-17 cells into the CNs through the choroid plexus is required for the initiation of eAe. Nat. Immunol. 10, 514-523 (2009).
74. Bending, D. et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/sCiD recipient mice. J. Clin. Invest. 119, 565-572 (2009).
75. Martin-Orozco, N., Chung, Y., Chang, S.H., Wang, Y.H. & Dong, C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 39, 216-224 (2009).
76. Muranski, P. et al. Tumor-specific Th17-polarized cells eradicate large established melanoma. blood 112, 362-373 (2008).
77. + T cells. Curr. opin. Immunol. 21, 200-208 (2009).
78. Boissier, M.C. et al. Biphasic Effect of Interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 25, 1184-1190 (1995).
79. Schnyder-Candrian, S. et al. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203, 2715-2725 (2006).
80. Wang, J. et al. Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest. 116, 414-421 (2006).
81. O'Connor, W. JR. et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603-609 (2009).
82. + T cells. Immunity 1, 553-562 (1994).
83. + T cells from iFN-γ knockout mice do not induce wasting disease. J. Autoimmun. 10, 455-459 (1997).
84. NEurath, M.F. et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129-1143 (2002).
85. simpson, S.J. et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (stat)-4 pathway, but is not conditional on Interferon-γ expression by T cells. J. Exp. Med. 187, 1225-1234 (1998).
86. Elson, C.O. et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132, 2359-2370 (2007).